Many varieties of proprietary Chinese medicines in China play a significant role in the prevention and treatment system. However, due to the characteristics of Chinese medicines that vary from person to person and the research methods are not in line with international standards, many Chinese medicine products have not received international recognition for their efficacy. China's traditional Chinese medicine can not enter the bottleneck of the international mainstream pharmaceutical market.
Evidence-based medicine is a western medicine research method that has risen in the world in recent years. Its research feature is a large-scale, multi-sample, double-blind trial. Therefore, the research results are objective, fair, and authoritative. Through evidence-based medical research, internationally-recognized drug efficacy evaluations can be drawn and drugs that are truly worth the trust of doctors and patients can be selected. There is very little research on evidence-based medicine in Chinese medicine, and research has just begun.
At the 4th International Collaborative Congress on Epidemiology held in Nanjing on November 15th, the Chinese Medical Association's Electrophysiology and Pacing Branch released exciting news. The anti-arrhythmic drug developed by Ling Medicine Group Co., Ltd. The comprehensive research on international evidence-based medicine conducted by Yangxin capsules is completed. This is the only anti-arrhythmia medicine in China that conducts evidence-based medical research. This research has been carried out in 36 large-scale comprehensive top-three hospitals across the country, including Beijing Fuwai. There are more than 500 medical experts participating in the Cardiovascular Hospital, Chaoyang Hospital of Capital Medical University, First Affiliated Hospital of Nanjing Medical University and Qilu Hospital of Shandong University. Studies have shown that the capsule treatment of non-organic premature ventricular contractions was significantly better than the control group, the treatment of organic ventricular premature beats significantly better than Western medicine slow heart rate; treatment of paroxysmal atrial fibrillation and Western medicine heart rate is equal, and the current Slow arrhythmia without effective Western medicine treatment such as sinus sinus, sick sinuses, conduction block, slow-slow syndrome, etc. also have a good effect, filling the gap in the treatment of slow arrhythmia drugs. This indicates that Chinese medicine is comparable to western medicine even more than Western medicine in certain therapeutic areas.
Experts at the meeting unanimously agreed that it is of great significance to carry out clinical research on evidence-based medicine in comparison with Western medicine. The biggest problem in the treatment of arrhythmia with Western medicine is its toxic and side effects, and many drugs have effective doses and side reactions. The doses are very similar. Without adequate doses, arrhythmias cannot be controlled, and if used at full doses, more serious arrhythmias may occur, and even mortality from cardiovascular diseases may increase. The research of Shensong Yangxin capsule has provided safe and effective drugs for many patients with arrhythmia, which has played a positive role in the clinical research of Chinese proprietary Chinese medicines and showed that the traditional Chinese medicine research methods can be evaluated by Chinese medicines at home and abroad. It has a convincing effect, which is of great significance for the modernization and internationalization of Chinese medicine.